Education
About Us
Working with TipRanks
Follow Us
SPEU - ETF AI Analysis
Top Page
SPDR Portfolio Europe ETF (SPEU)
Rating:63Neutral
Price Target:―
Positive Factors
Broad European Diversification
The fund spreads its investments across many European countries, which helps reduce the impact if any single market struggles.
Low Expense Ratio
The ETF charges a relatively low fee, so less of your return is eaten up by costs over time.
Solid Recent Performance
The ETF has shown steady gains over the past few months, suggesting recent momentum in its underlying holdings.
Negative Factors
Heavy Financials Exposure
A large share of the portfolio is in financial companies, which can make the fund more sensitive to changes in interest rates and the banking sector.
Mixed Performance Among Top Holdings
While some major positions have performed strongly, others have been weak, which can create uneven results for the fund.
Regional Concentration in Europe
The ETF is focused mainly on European markets, so it may be more affected by Europe-specific economic or political issues and offers limited exposure to other regions.
SPEU vs. SPDR S&P 500 ETF (SPY)
AUM793.68M
RegionEurope
Expense Ratio0.07%
Beta0.64
IssuerState Street
Inception DateOct 15, 2002
Dividend Yield3.26%
Asset ClassEquity
Index TrackedSTOXX Europe TMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume69,166
30 Day Avg. Volume63,908
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.18Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1679
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPEU Summary
SPEU is the SPDR Portfolio Europe ETF, which follows the STOXX Europe TMI index. It gives you broad exposure to European stocks across many countries and sectors, from banks and industrial firms to healthcare and technology. Well-known holdings include ASML and Nestlé. Someone might invest in SPEU to diversify beyond the U.S. and spread their money across many European companies in a single, low-cost fund. A key risk is that the value can go up and down with the European stock market and may be affected by economic or political issues in Europe.
How much will it cost me?The SPDR Portfolio Europe ETF (SPEU) has an expense ratio of 0.07%, meaning you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically involves fewer costs compared to actively managed funds.
What would affect this ETF?The SPDR Portfolio Europe ETF (SPEU) could benefit from positive economic growth in Europe, particularly in sectors like financials, industrials, and healthcare, which make up a significant portion of its holdings. However, challenges such as rising interest rates, regulatory changes, or economic slowdowns in developed European markets could negatively impact the ETF's performance. Additionally, fluctuations in the performance of top holdings like ASML, Nestlé, and AstraZeneca may influence the fund's returns.
SPEU Top 10 Holdings
SPEU leans heavily into Europe’s blue-chip story, with Dutch chip-equipment giant ASML doing much of the heavy lifting as one of the fund’s strongest, most consistently rising names. Big Swiss pharma players like Roche and Novartis are also pulling their weight, keeping the health care sleeve on a steady upward path. On the flip side, German software leader SAP has been losing steam lately, and consumer staple heavyweight Nestlé has been lagging, slightly dulling returns. Overall, the ETF is broadly diversified across developed Europe, with notable tilts toward financials, industrials, and health care rather than any single stock or country.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.44% | $27.53M | €475.49B | 73.03% | 76 Outperform | |
| Roche Holding AG | 2.02% | $16.21M | CHF294.84B | 47.36% | 73 Outperform | |
| AstraZeneca | 1.96% | $15.74M | £240.98B | 31.92% | 80 Outperform | |
| Novartis AG | 1.90% | $15.22M | CHF242.43B | 30.85% | 80 Outperform | |
| HSBC Holdings | 1.82% | $14.55M | £222.90B | 45.67% | 80 Outperform | |
| Nestlé SA | 1.58% | $12.62M | CHF198.29B | 15.97% | 71 Outperform | |
| Shell (UK) | 1.37% | $11.01M | £165.51B | 9.69% | 73 Outperform | |
| Siemens | 1.31% | $10.49M | €191.01B | 9.04% | 74 Outperform | |
| SAP SE | 1.26% | $10.06M | €197.41B | -37.90% | 66 Neutral | |
| Banco Santander | 1.13% | $9.08M | €157.30B | 90.26% | 73 Outperform |
SPEU Technical Analysis
Positive
―
Price Trends
53.36
Positive
51.51
Positive
49.48
Positive
Market Momentum
0.64
Positive
59.49
Neutral
77.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 55.00, equal to the 50-day MA of 53.36, and equal to the 200-day MA of 49.48, indicating a bullish trend. The MACD of 0.64 indicates Positive momentum. The RSI at 59.49 is Neutral, neither overbought nor oversold. The STOCH value of 77.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPEU.
SPEU Peer Comparison
Comparison Results
Performance Comparison
SPEU
SPDR Portfolio Europe ETF
55.44
13.27
31.47%
VGK
Vanguard FTSE Europe ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
FEUZ
First Trust Eurozone AlphaDEX ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents